{"page":{"totalFilteredElements":344},"studies":[{"active":true,"description":"A Phase II Trial of Teclistamab in participants with previously treated Immunoglobulin Light-Chain (AL) Amyloidosis","eudractNumber":"2024-519191-90-00","id":11509,"indications":[{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym3","name":"Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)"}],"mutations":[],"nctNumber":"NCT06649695","phase":{"id":"ph_7","name":"Phase II"},"recruitmentStart":"2025-07-25T13:24:44+02:00","shortTitle":"EMN 40","therapeutical":true,"therapyLines":[{"id":"tl_2","name":"Zweitlinie"}]},{"active":true,"description":"Deutsches Nebennierenkarzinom Register -->
seit 17.06.2011:
Register und Biobank des Europäischen Netzwerks für Nebennierentumoren ENS@T (European Network for the Study of Adrenal Tumours)
","eudractNumber":null,"id":94,"indications":[{"id":"nen","name":"Bösartige Tumoren der Nebenniere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2003-01-01T09:48:37+01:00","shortTitle":"ENSAT-Register","therapeutical":false,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"

 Surgery as\nneeded versus surgery on principle in patients with postneoadjuvant\nclinical complete tumor response of esophageal\ncancer - ESORES-Trial 

DRKS00022801

","eudractNumber":null,"id":10294,"indications":[{"id":"gio","name":"Bösartige Erkrankungen des oberen Verdauungstraktes (Oesophagus, Magen, gastrooesophagealer Übergang)"},{"id":"gio1","name":"Karzinom der Speiseröhre (Oesophaguskarzinom, inkl. gastrooesophagealer Übergang)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_13","name":"Therapieoptimierung"},"recruitmentStart":"2024-10-15T09:16:00+02:00","shortTitle":"ESORES","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"A multinational registry for rhabdoid tumors of any anatomical site / EU-RHAB-Register (AT/RT)","eudractNumber":null,"id":232,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped3","name":"Hirntumore (Tumore des zentralen Nervensystems)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2010-11-15T10:59:53+01:00","shortTitle":"EU-RHAB","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants with Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)

D798EC00001
","eudractNumber":"2023-506294-36","id":9113,"indications":[{"id":"hno","name":"Kopf/Hals Tumoren"},{"id":"hno3","name":"Kopf-Hals-Malignome"}],"mutations":[{"name":"CTLA-4 (cytotoxic T-lymphocyte-associated Protein 4)","id":"mt_42"},{"name":"HPV16","id":"mt_86"},{"name":"PD-1 (Programmed cell death protein 1)","id":"mt_43"},{"name":"PD-L1","id":"mt_25"}],"nctNumber":"NCT06129864","phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2024-10-21T10:45:37+02:00","shortTitle":"EVOLVE-HNSCC D798EC00001","therapeutical":true,"therapyLines":[{"id":"tl_6","name":"Adjuvant"}]},{"active":true,"description":"Prospektiv-randomisierte, multizentrische Studie zur Verkürzung der Wartezeit bis zur Transplantation durch Qualitätsbeurteilung abgelehnter Leber-transplantate mittels ex vivo Maschinenperfusion","eudractNumber":null,"id":11689,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu2","name":"Leber (Hepatozelluläres Karzinom, HCC) / Gallenblase-/wege (Cholangiozelluläres Karzinom, CCC)"}],"mutations":[],"nctNumber":"NCT06874296","phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2026-02-05T09:28:01+01:00","shortTitle":"EXTRA","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Einzelzellanalysen kutane Malignome“ ( Charakterisierung von kutanen Malignomen und deren Mikroumgebung durch Einzelzellanalysen von Tumor, Blut und Lymphknotengewebe) ","eudractNumber":null,"id":11303,"indications":[{"id":"hau","name":"Hauttumoren"},{"id":"hau1","name":"Malignes Melanom"},{"id":"hau2","name":"Basaliom"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym3","name":"Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2025-03-25T11:24:44+01:00","shortTitle":"Einzelzellanalysen kutane Malignome","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Psychische Belastung von Krebspatienten im Verlauf der onkologischen Behandlung (Brustzentrum)

Epidemiologische\nUntersuchung zur Belastung von Krebspatienten (Verbesserung der Erkennung des\npsychoonkologischen Betreuungsbedarfs bei Krebspatienten)
","eudractNumber":null,"id":5262,"indications":[{"id":"bru","name":"Brustkrebs (Mammakarzinom)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2018-08-28T10:12:21+02:00","shortTitle":"Erkennung des psychoonkologischen Betreuungsbedarfs bei Krebspatienten (Brust)","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Psychische Belastung von Krebspatienten im Verlauf der onkologischen Behandlung (Darmzentrum)

Epidemiologische\nUntersuchung zur Belastung von Krebspatienten (Verbesserung der Erkennung des\npsychoonkologischen Betreuungsbedarfs bei Krebspatienten)
","eudractNumber":null,"id":5261,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2018-05-24T10:12:28+02:00","shortTitle":"Erkennung des psychoonkologischen Betreuungsbedarfs bei Krebspatienten (Darm)","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Erstellung eines detaillierten Immunprofils von Tumorerkrankungen (EdIT)","eudractNumber":null,"id":5558,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu3","name":"Bauchspeicheldrüsenkrebs (Pankreaskarzinom)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2019-07-01T14:43:34+02:00","shortTitle":"Erstellung eines detaillierten Immunprofils von Tumorerkrankungen (EdIT)","therapeutical":false,"therapyLines":[]}]}